J. Adkins

发表

A somatic reference standard for cancer genome sequencing

Steven J. M. Jones, Richard A. Moore, Winnie S. Liang, 2016, Scientific Reports.

Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas

Rebecca F. Halperin, Sean R. Dinn, Winnie S. Liang, 2019, PloS one.

Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples

Winnie S. Liang, S. Byron, R. Korn, 2019, Front. Oncol..

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Eric W. Klee, Stephen D. Mastrian, Ahmet Kurdoglu, 2014, PLoS genetics.

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

J. Cheville, J. Carpten, D. Craig, 2016, Clinical genitourinary cancer.

Tumor cell phenotype and heterogeneity differences in IDH1 mutant vs wild-type gliomas

Rebecca F. Halperin, Sean R. Dinn, Winnie S. Liang, 2019, bioRxiv.

Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.

Rebecca F. Halperin, Winnie S. Liang, J. Carpten, 2017, Genome research.

Identification of therapeutic targets in chordoma through comprehensive genomic and transcriptomic analyses

S. Byron, W. Liang, A. Little, 2018, Cold Spring Harbor molecular case studies.

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

Winnie S. Liang, J. Carpten, J. Trent, 2018, Investigational New Drugs.

Identification of Initiating Trunk Mutations and Distinct Molecular Subtypes: An Interim Analysis of the Mmrf Commpass Study

J. Carpten, J. Fay, S. Jewell, 2015 .

Interim Analysis of the Mmrf Commpass Trial: Identification of Novel Rearrangements Potentially Associated with Disease Initiation and Progression

Winnie S. Liang, J. Carpten, S. Jewell, 2014 .

Molecular Predictors of Outcome and Drug Response in Multiple Myeloma: An Interim Analysis of the Mmrf CoMMpass Study

Winnie S. Liang, J. Carpten, J. Fay, 2016 .

MKS1 regulates ciliary INPP5E levels in Joubert syndrome

Colin A. Johnson, I. Glass, S. Bowdin, 2015, Journal of Medical Genetics.

Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects

Winnie S. Liang, W. Liang, J. Adkins, 2018, bioRxiv.

Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes

Ahmet Kurdoglu, Jessica Aldrich, Eric M. Reiman, 2015, Neurobiology of Aging.

Tumor cell phenotype and heterogeneity differences in IDH1 mutant vs wild-type gliomas

Sean R. Dinn, M. Prados, S. Nelson, 2019, bioRxiv.

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

Winnie S. Liang, J. Carpten, D. Craig, 2016, Scientific Reports.

Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity

J. Shendure, B. O’Roak, I. Glass, 2015, Journal of Medical Genetics.

Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing

Hugo Y. K. Lam, Winnie S. Liang, Daoud M. Meerzaman, 2021, Nature Biotechnology.

Joint analysis of matched tumor samples with varying tumor contents improves somatic variant calling in the absence of a germline sample

S. Byron, R. Korn, Seungchan Kim, 2018, bioRxiv.

Joubert syndrome: brain and spinal cord malformations in genotyped cases and implications for neurodevelopmental functions of primary cilia

R. Hevner, D. Doherty, J. Adkins, 2012, Acta Neuropathologica.

Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors.

L. Rimsza, Y. Lussier, W. Liang, 2015, Cancer research.

Non-recurrent SEPT9 duplications cause hereditary neuralgic amyotrophy

H. Mefford, E. Eichler, K. Buysse, 2009, Journal of Medical Genetics.

Genotype–phenotype correlation in CC2D2A-related Joubert syndrome reveals an association with ventriculomegaly and seizures

Shashidhar Pai, Ian Glass, Louise Izatt, 2012, Journal of Medical Genetics.

Genomic tumor analysis provides clinical guidance for the management of diagnostically challenging cancers in dogs.

Sharadha Sakthikumar, W. Hendricks, J. Adkins, 2023, Journal of the American Veterinary Medical Association.

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

Rebecca F. Halperin, Winnie S. Liang, N. Schork, 2021, PloS one.

TMEM237 is mutated in individuals with a Joubert syndrome related disorder and expands the role of the TMEM family at the ciliary transition zone.

Colin A. Johnson, C. Ober, R. Hegele, 2011, American journal of human genetics.

Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass Study

Winnie S. Liang, J. Carpten, S. Jewell, 2021, medRxiv.

Whole Exome Library Construction for Next Generation Sequencing.

J. Keats, W. Liang, J. Adkins, 2018, Methods in molecular biology.

Whole Genome Library Construction for Next Generation Sequencing.

Winnie S. Liang, J. Keats, W. Liang, 2018, Methods in molecular biology.

Interim Analysis of the MMRF CoMMpass Study: Comprehensive Characterization of Multiple Myeloma Patients at Diagnosis Reveals Distinct Molecular Subtypes and Clinical Outcomes

Winnie S. Liang, J. Carpten, J. Fay, 2015 .

ACValidator: A novel assembly-based approach for in silico verification of circular RNAs

Winnie S. Liang, Jonathan Adkins, Geidy Serrano, 2020, Biology methods & protocols.

ACValidator: a novel assembly-based approach for in silico validation of circular RNAs

Philipp Geiger, Winnie S. Liang, Shobana Sekar, 2019, bioRxiv.

Identification of therapeutic targets in chordoma through comprehensive genomic and transcriptomic analyses

Winnie S. Liang, S. Byron, A. Little, 2018, Cold Spring Harbor molecular case studies.

Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors.

Winnie S. Liang, L. Rimsza, Y. Lussier, 2015, Cancer research.